Livzon Pharmaceutical Group Inc. (SHE:000513)

China · Delayed Price · Currency is CNY

34.53

+0.38 (1.11%)

Apr 8, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020	FY 2018	FY 2018	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022	Jan '21 Jan 1, 2021	Jan '20 Jan 1, 2020	Dec '18 Dec 31, 2018	Jan '18 Jan 1, 2018	Dec '16 Dec 31, 2016
Pharmaceutical Manufacturing	12.02B	11.81B	12.43B	12.63B	12.06B
Pharmaceutical Manufacturing Growth	1.76%	-4.97%	-1.58%	4.69%	14.67%
Total	12.02B	11.81B	12.43B	12.63B	12.06B
Total Growth	1.76%	-4.97%	-1.58%	4.69%	14.67%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020	FY 2018	FY 2018	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022	Jan '21 Jan 1, 2021	Jan '20 Jan 1, 2020	Dec '18 Dec 31, 2018	Jan '18 Jan 1, 2018	Dec '16 Dec 31, 2016
China	9.97B	9.98B	10.75B	10.96B	10.39B
China Growth	-0.10%	-7.23%	-1.86%	5.48%	18.90%
Overseas	1.93B	1.72B	1.57B	1.57B	1.54B
Overseas Growth	11.97%	9.69%	0.40%	1.72%	-10.82%
Total	11.90B	11.70B	12.33B	12.52B	11.93B
Total Growth	1.68%	-5.07%	-1.58%	4.99%	14.00%

Source: S&P Global Market Intelligence.